Emerging countries such as India are expected to bet on massive opportunities from the sale of diafenthiuron, an off-patented insecticide product, by the first quarter of 2018. Thousands of crores of gross sales could be targeted by Insecticides India round about the same period. The management anticipates a handsome revenue to be earned from both B2B and B2C segments through diafenthiuron sales.